Integrated diabetes care Glooko offers an end-to-end diabetes management platform spanning outpatient and inpatient settings, with recent expansions including GestationalCare and Tandem pump data integration, presenting opportunities to upsell to health systems seeking unified glycemic management across care settings.

Data connectivity leverage Recent launches such as Pump Settings EHR Integration and automatic insulin pump data access reduce manual workflows, enabling sales conversations around EHR-based efficiency, interoperability, and improved clinician burden reduction.

Expansion momentum Frequent product updates and partnerships, plus active attendance at major events (ADA Product Theater, industry meetings) signal a growth trajectory and provide chances to position Glooko as the central platform for expanding diabetes care programs.

Financial scale With a revenue range of $50M-$100M and substantial funding, Glooko demonstrates financial viability and runway to support enterprise deployments, multi-site rollouts, and long-term contracted deployments with health systems.

Strategic partnerships The company’s use of multiple tech stacks and cloud-based tools, plus collaborations with device integrations (Tandem) and remote monitoring (Glooko XT), creates opportunities to bundle with device manufacturers, payers, and ambulatory/inpatient programs seeking turnkey digital health solutions.